Pharma Aims Torpedo At FCA After Bombshell 9th Circ. Ruling

By Jeff Overley · May 1, 2026, 10:27 PM EDT

A burgeoning campaign against the False Claims Act's whistleblower mechanism is suddenly center stage at the Ninth Circuit, where pharmaceutical companies say a momentous new ruling "illustrates perfectly" the constitutional concerns...

To view the full article, register now.

Documents

Case Information

Case Title

United States of America et al v. AbbVie Inc. et al

Case Number

2:21-cv-04249

Court

California Central

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

May 21, 2021


Case Title

Adventist Health System of West v. AbbVie Inc., et al.

Case Number

24-2180

Court

Appellate - 9th Circuit

Nature of Suit

Date Filed

April 08, 2024